Provided by Tiger Trade Technology Pte. Ltd.

Valneva SE

10.32
-0.1750-1.67%
Post-market: 10.320.00000.00%17:35 EDT
Volume:3.39K
Turnover:35.41K
Market Cap:896.57M
PE:-6.55
High:10.60
Open:10.60
Low:10.31
Close:10.50
52wk High:12.25
52wk Low:5.43
Shares:86.88M
Float Shares:64.58M
Volume Ratio:0.19
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5760
EPS(LYR):-1.5968
ROE:-80.16%
ROA:-11.35%
PB:7.29
PE(LYR):-6.46

Loading ...

Guggenheim Reaffirms Their Buy Rating on Valneva (VALN)

TIPRANKS
·
Mar 19

Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (STOK), Valneva (VALN) and Protagonist Therapeutics (PTGX)

TIPRANKS
·
Mar 19

Goldman Sachs Reaffirms Their Hold Rating on Valneva (VALN)

TIPRANKS
·
Mar 19

Valneva Licenses C. Difficile Antigen Technology to Elaris

MT Newswires Live
·
Mar 18

Elaris FlexCo secures exclusive global license from Valneva

TIPRANKS
·
Mar 18

Valneva 2025 Loss Widens, Revenue Rises; Shares Down Pre-Bell

MT Newswires Live
·
Mar 18

Valneva Q4 EPS $(0.68) Misses $(0.21) Estimate, Sales $55.516M Miss $56.190M Estimate

Benzinga
·
Mar 18

Press Release: Valneva Reports Full Year 2025 Audited Consolidated Financial Results

Dow Jones
·
Mar 18

Valneva SE expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
Mar 16

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Oxford BioMedica (OtherOXBDF), Valneva (VALN) and Supernus Pharmaceuticals (SUPN)

TIPRANKS
·
Feb 27

Valneva FY 2025 third-party product sales EUR 19.2 million -42.3%

Reuters
·
Feb 19

BUZZ-Valneva jumps on 'attractive' risk/reward profile ahead of vaccine's phase 3 results

Reuters
·
Feb 04

Valneva, Instituto Butantan Start Pilot Program for Chikungunya Vaccine in Brazil

MT Newswires Live
·
Feb 03

Valneva Steps Back From US Approval Bid For Chikungunya Vaccine

Benzinga_recent_news
·
Jan 21

Valneva, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Benzinga
·
Jan 20

Valneva withdraws BLA, IND application for Ixchiq in U.S.

TIPRANKS
·
Jan 20

Valneva SE Terminates Vaccine Deal with Serum Institute

MT Newswires Live
·
Jan 01

First Berlin Equity Research Raises Valneva SE Price Target to €6.80

Reuters
·
Dec 08, 2025

Analysts Offer Insights on Healthcare Companies: Valneva (VALN) and Neurocrine (NBIX)

TIPRANKS
·
Nov 28, 2025

Valneva to Consolidate French Operations in Lyon

MT Newswires Live
·
Nov 27, 2025